Zhejiang Orient Gene Biotech Second Quarter 2024 Earnings: CN¥0.43 loss per share (vs CN¥0.41 profit in 2Q 2023)

Simply Wall St · 08/31 00:08

Zhejiang Orient Gene Biotech (SHSE:688298) Second Quarter 2024 Results

Key Financial Results

  • Revenue: CN¥235.3m (up 88% from 2Q 2023).
  • Net loss: CN¥84.3m (down by 199% from CN¥85.1m profit in 2Q 2023).
  • CN¥0.43 loss per share (down from CN¥0.41 profit in 2Q 2023).
earnings-and-revenue-history
SHSE:688298 Earnings and Revenue History August 31st 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

Zhejiang Orient Gene Biotech shares are up 8.5% from a week ago.

Risk Analysis

You should learn about the 1 warning sign we've spotted with Zhejiang Orient Gene Biotech.